We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+11.66%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$115B
AUM Growth
+$4.93B
(+4.5%)
Cap. Flow
-$5.87B
Cap. Flow
% of AUM
-5.12%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,953
New
141
Increased
711
Reduced
931
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$234M |
| 2 |
Gilead Sciences
GILD
|
+$172M |
| 3 |
CVS Health
CVS
|
+$169M |
| 4 |
Public Service Enterprise Group
PEG
|
+$158M |
| 5 |
Bank of America
BAC
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$338M |
| 2 |
JPMorgan Chase
JPM
|
+$288M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$276M |
| 4 |
Medtronic
MDT
|
+$257M |
| 5 |
Advanced Micro Devices
AMD
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Healthcare | 12.6% |
| 3 | Financials | 12.53% |
| 4 | Industrials | 10.94% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Intellia Therapeutics
NTLA
$1.58B
| $4.14M | ﹤0.01% |
135,637
-10,784
| -7% | -$310K |
|
952
Oaktree Specialty Lending
OCSL
$1.07B
| $4.13M | ﹤0.01% |
202,106
-14,509
| -7% | -$287K |
|
953
International Flavors & Fragrances
IFF
$20.7B
| $4.1M | ﹤0.01% |
50,594
+14,772
| +41% | +$1.07M |
|
954
RPM International
RPM
$14.7B
| $4.09M | ﹤0.01% |
36,666
+13,296
| +57% | +$1.34M |
|
955
Centene
CNC
$31.7B
| $4.08M | ﹤0.01% |
55,028
+5,724
| +12% | +$413K |
|
956
Kosmos Energy
KOS
$1.44B
| $4.08M | ﹤0.01% |
608,176
+150,133
| +33% | +$1.05M |
|
|
SEE
957
DELISTED
Sealed Air
SEE
| $4.03M | ﹤0.01% |
110,400
+9,962
| +10% | +$327K |
|
958
Dow Inc
DOW
$21.9B
| $4M | ﹤0.01% |
73,013
-9,982
| -12% | -$510K |
|
|
ITCI
959
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4M | ﹤0.01% |
55,851
+49,607
| +794% | +$2.85M |
|
960
Fastenal
FAST
$57B
| $3.98M | ﹤0.01% |
122,844
+83,924
| +216% | +$2.53M |
|
|
961
Bank of America Series L
BAC.PRL
$3.98B
| $3.97M | ﹤0.01% |
3,294
+103
| +3% | +$115K |
|
962
Ralph Lauren
RL
$22.5B
| $3.96M | ﹤0.01% |
27,473
+5,836
| +27% | +$723K |
|
|
BPMC
963
DELISTED
Blueprint Medicines
BPMC
| $3.92M | ﹤0.01% |
42,506
-14,261
| -25% | -$924K |
|
964
National Fuel Gas
NFG
$7.75B
| $3.9M | ﹤0.01% |
77,774
-12,178
| -14% | -$628K |
|
965
Labcorp
LH
$25.3B
| $3.9M | ﹤0.01% |
17,151
+9,333
| +119% | +$1.96M |
|
|
AVDX
966
DELISTED
AvidXchange
AVDX
| $3.88M | ﹤0.01% |
312,996
-21,530
| -6% | -$215K |
|
|
UMH
967
UMH Properties
UMH
$1.3B
| $3.87M | ﹤0.01% |
252,915
-27,737
| -10% | -$400K |
|
968
Sea Limited
SE
$68.3B
| $3.83M | ﹤0.01% |
94,501
+6,162
| +7% | +$251K |
|
969
Fidelity National Financial
FNF
$13.9B
| $3.83M | ﹤0.01% |
75,002
-7,424
| -9% | -$323K |
|
|
SMAR
970
DELISTED
Smartsheet Inc.
SMAR
| $3.77M | ﹤0.01% |
78,927
-23,789
| -23% | -$1.01M |
|
971
TPG
TPG
$7.86B
| $3.75M | ﹤0.01% |
86,903
-9,104
| -9% | -$307K |
|
972
Mueller Industries
MLI
$15.1B
| $3.74M | ﹤0.01% |
158,518
+107,998
| +214% | +$2.18M |
|
973
Warby Parker
WRBY
$3.67B
| $3.71M | ﹤0.01% |
262,840
+48,078
| +22% | +$599K |
|
974
McCormick & Company Non-Voting
MKC
$14B
| $3.7M | ﹤0.01% |
54,105
+17,969
| +50% | +$1.18M |
|
975
Saia
SAIA
$9.99B
| $3.69M | ﹤0.01% |
8,421
-11,139
| -57% | -$4.5M |
|
Similar funds
Neuberger Berman Group's Q4 2023 Portfolio in Review
As of Q4 2023, Neuberger Berman Group held 1,953 positions worth $115B, up 4.5% from $110B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Neuberger Berman Group withdrew a net $5.87B in Q4 2023, closing 90 positions and reducing 931 holdings. Its most notable exit was Activision Blizzard, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Neuberger Berman Group opened a new position in Avantis Emerging Markets Equity ETF worth $27.4M.
- Neuberger Berman Group's largest Q4 2023 buy was Avantis Emerging Markets Equity ETF: 486,139 shares worth $27.4M.
- Neuberger Berman Group added most to UnitedHealth in Q4 2023, an estimated $234M increase.
- Neuberger Berman Group's biggest Q4 2023 reduction was Chevron, cutting an estimated $338M.
- Neuberger Berman Group fully exited Activision Blizzard in Q4 2023, selling an estimated $276M.
- Neuberger Berman Group's ten largest holdings make up 17% of its $115B portfolio in Q4 2023.
- Neuberger Berman Group opened 141 new positions and closed 90 in Q4 2023.
- Neuberger Berman Group's portfolio value rose 4.5% quarter-over-quarter to $115B.
Based on Neuberger Berman Group's 13F filing for Q4 2023, filed 9 Feb 2024.